STOCK TITAN

The Sherwin-Williams Company (SHW) Financials

SHW
Trailing 12 months to June 30, 2026
Revenue $24.4B +5.8% YoY
Net Income $2.7B +5.6% YoY
EPS (Diluted) $10.85 +7.6% YoY
Free Cash Flow $3.2B +49.1% YoY
Market Cap $78.8B as of Sep 14, 2026
Price / Sales 3.2x on $24.4B revenue, trailing 12 months to June 30, 2026
Price / Earnings 29.3x on $2.7B net income, trailing 12 months to June 30, 2026
Price / Book 20.4x on $3.9B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SHW SEC filings page.

The Sherwin-Williams Company (SHW) reported $24.4B in revenue over the twelve months to Jun 30, 2026, up 5.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SHW FY2025

Sherwin-Williams combines gross-margin expansion with cash conversion and a leveraged balance sheet, rather than translating all product-cost gains into net income.

Gross margin widened from 46.7% in FY2023 to 48.9% in FY2025, but bottom-line conversion weakened after FY2024. Net margin fell to 10.9% in FY2025 from 11.6% in FY2024, indicating that gains at the product-cost line were partly absorbed below gross profit.

Operating cash flow exceeded net income in FY2025, showing that reported earnings converted into more operating cash than they contained. Free cash flow recovered to $2.65B as capital expenditures fell 25.5% from FY2024, making investment cadence a major determinant of cash available for financing.

Debt-to-equity declined from 3.5x in FY2021 to 2.0x in FY2025 as equity expanded faster than debt, so leverage eased without becoming immaterial. The FY2025 current ratio was 0.9x, meaning current liabilities exceeded current assets and short-term financing remains reliant on liability management.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 54 / 100
Financial Health Score 54/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of The Sherwin-Williams Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
87
Growth
34

The Sherwin-Williams Company's revenue grew a modest 2.1% year-over-year to $23.6B. This slow but positive growth earns a score of 34/100.

Leverage
31

The Sherwin-Williams Company has a moderate D/E ratio of 2.03. This balance of debt and equity financing earns a leverage score of 31/100.

Liquidity
14

The Sherwin-Williams Company's current ratio of 0.87 is below the typical benchmark, resulting in a score of 14/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
67

The Sherwin-Williams Company converts 11.3% of revenue into free cash flow ($2.7B). This strong cash generation earns a score of 67/100.

Returns
93

The Sherwin-Williams Company earns a strong 55.9% return on equity (ROE), meaning it generates $56 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 93/100. This is down from 66.2% the prior year.

Piotroski F-Score Neutral
6/9

The Sherwin-Williams Company passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.34x

For every $1 of reported earnings, The Sherwin-Williams Company generates $1.34 in operating cash flow ($3.5B OCF vs $2.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.8B
YoY+7.5%
QoQ+19.8%
5Y CAGR+4.8%
10Y CAGR+7.7%

The Sherwin-Williams Company generated $6.8B in revenue in Q2 2026. This represents an increase of 7.5% from the same quarter a year earlier. Against the prior quarter it is up 19.8%.

Net Income
$843.6M
YoY+11.8%
QoQ+57.8%
5Y CAGR+5.4%
10Y CAGR+8.4%

The Sherwin-Williams Company reported $843.6M in net income in Q2 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is up 57.8%.

EPS (Diluted)
$3.43
YoY+14.3%
QoQ+59.5%
5Y CAGR+7.2%
10Y CAGR-1.5%

The Sherwin-Williams Company earned $3.43 per diluted share (EPS) in Q2 2026. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is up 59.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$1.2B
YoY+33.1%
QoQ+154787.5%
5Y CAGR+6.2%
10Y CAGR+9.3%

The Sherwin-Williams Company generated $1.2B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 33.1% from the same quarter a year earlier. Against the prior quarter it is up 154787.5%.

Cash & Debt
$293.5M
YoY+8.8%
QoQ+35.3%
5Y CAGR+6.0%
10Y CAGR-3.1%

The Sherwin-Williams Company held $293.5M in cash against $8.3B in long-term debt as of Q2 2026.

Dividends Per Share
$0.80
YoY+1.3%
QoQ0.0%

The Sherwin-Williams Company paid $0.80 per share in dividends in Q2 2026. This represents an increase of 1.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
243M
YoY-2.6%
QoQ-1.6%
5Y CAGR-1.6%
10Y CAGR+10.2%

The Sherwin-Williams Company had 243M shares outstanding in Q2 2026. This represents a decrease of 2.6% from the same quarter a year earlier. Against the prior quarter it is down 1.6%.

Margins & Returns

Gross Margin
49.2%
YoY-0.2pp
QoQ+0.1pp
5Y change+4.4pp
10Y change-1.6pp

The Sherwin-Williams Company's gross margin was 49.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Net Margin
12.4%
YoY+0.5pp
QoQ+3.0pp
5Y change+0.4pp
10Y change+0.7pp

The Sherwin-Williams Company's net profit margin was 12.4% in Q2 2026, showing the share of revenue converted to profit. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.

Return on Equity
21.9%
YoY+4.7pp
QoQ+9.8pp
5Y change-1.0pp
10Y change-8.5pp

The Sherwin-Williams Company's ROE was 21.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.8 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$1.3B
YoY+143.3%
QoQ+119.1%
5Y CAGR+7.7%

The Sherwin-Williams Company spent $1.3B on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 143.3% from the same quarter a year earlier. Against the prior quarter it is up 119.1%.

Capital Expenditures
$108.4M
YoY-40.3%
QoQ-21.6%
5Y CAGR+4.5%
10Y CAGR+5.7%

The Sherwin-Williams Company invested $108.4M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 40.3% from the same quarter a year earlier. Against the prior quarter it is down 21.6%.

R&D Spending

Not reported for Q2 2026.

SHW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SHW quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$6.8B+7.5%$5.7B+6.8%$5.6B+5.6%$6.4B+3.2%$6.3B+0.7%$5.3B-1.1%$5.3B+0.9%$6.2B+0.7%
Cost of Revenue$3.5B+8.0%$2.9B+5.1%$2.9B+5.8%$3.2B+3.1%$3.2B-0.4%$2.7B-3.2%$2.7B+0.8%$3.1B-2.0%
Gross Profit$3.3B+7.0%$2.8B+8.7%$2.7B+5.4%$3.1B+3.2%$3.1B+1.8%$2.6B+1.1%$2.6B+1.0%$3.0B+3.8%
SG&A Expenses$2.1B+4.6%$2.0B+9.8%$1.9B+2.9%$2.0B+3.1%$2.0B+9.0%$1.8B-0.3%$1.9B+1.5%$1.9B+7.8%
Operating IncomeN/AN/AN/AN/AN/AN/AN/A$1.3B+1.7%
EBITDAN/AN/AN/AN/AN/AN/AN/A$1.5B+1.5%
Interest Expense$135.9M+20.9%$131.6M+26.8%$62.8M+67.5%$117.2M+13.3%$112.4M+1.4%$103.8M+0.8%$37.5M-60.4%$103.4M+1.5%
Income Tax$268.9M+16.4%$145.1M-2.7%$162.2M+19.7%$227.4M+5.0%$231.0M-18.5%$149.1M+10.6%$135.5M+15.0%$216.6M-12.5%
Net Income$843.6M+11.8%$534.7M+6.1%$476.8M-0.7%$833.1M+3.3%$754.7M-15.2%$503.9M-0.3%$480.1M+34.8%$806.2M+5.9%
EPS (Basic)$3.46+13.8%$2.18+7.9%$1.94+1.0%$3.38+5.0%$3.04-14.4%$2.02+1.0%$1.92+36.2%$3.22+8.1%
EPS (Diluted)$3.43+14.3%$2.15+7.5%$1.92+1.1%$3.35+5.3%$3.00-14.3%$2.00+1.5%$1.90+35.7%$3.18+7.8%
Diluted Shares (Avg)246M-2.1%248M-1.7%N/A249M-1.9%251M-1.1%253M-1.3%N/A254M-1.7%

Not reported in any period shown, so not listed: R&D Expenses.

SHW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SHW quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$27.0B+6.3%$26.4B+7.1%$25.9B+9.6%$26.2B+9.3%$25.4B+6.9%$24.6B+5.2%$23.6B+3.0%$24.0B+4.2%
Current Assets$7.0B+8.9%$6.5B+7.6%$6.0B+11.2%$6.1B+2.9%$6.4B+6.2%$6.0B+3.4%$5.4B-2.0%$6.0B-3.6%
Cash & Equivalents$293.5M+8.8%$216.9M+8.6%$207.2M-1.5%$241.5M+1.4%$269.8M+34.9%$199.8M+11.1%$210.4M-24.0%$238.2M-52.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$2.5B+1.8%$2.5B-1.7%$2.3B+1.3%$2.3B+0.4%$2.5B+8.5%$2.5B+5.8%$2.3B-1.8%$2.3B+1.0%
Accounts Receivable$3.6B+14.8%$3.2B+13.5%$2.8B+16.8%$3.1B+5.0%$3.1B+2.1%$2.8B+0.1%$2.4B-3.2%$3.0B+1.1%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$8.0B+2.8%$8.0B+3.8%$8.0B+6.0%$7.8B+1.8%$7.8B+2.6%$7.7B+1.1%$7.6B-0.6%$7.7B+3.3%
Total Liabilities$23.1B+10.2%$21.9B+7.0%$21.3B+8.8%$21.8B+9.9%$21.0B+4.9%$20.5B+2.9%$19.6B+1.8%$19.8B+3.1%
Current Liabilities$9.6B+17.5%$7.5B-4.3%$6.9B+1.6%$7.5B+3.5%$8.2B+9.8%$7.9B+5.3%$6.8B+2.7%$7.2B+9.0%
Non-Current Liabilities$13.5B+5.5%$14.4B+14.1%$14.4B+12.6%$14.3B+13.6%$12.8B+2.0%$12.6B+1.5%$12.8B+1.3%$12.6B-0.1%
Long-Term Debt$8.3B+6.4%$9.3B+19.1%$9.3B+14.0%$9.3B+14.0%$7.8B-3.7%$7.8B-3.7%$8.2B-2.4%$8.2B-3.8%
Total Equity$3.9B-12.4%$4.4B+7.3%$4.6B+13.5%$4.4B+6.5%$4.4B+17.3%$4.1B+17.9%$4.1B+9.0%$4.2B+9.9%
Retained Earnings$2.0B-75.2%$1.4B-81.9%$1.0B-85.8%$8.7B+25.9%$8.1B+28.2%$7.5B+34.6%$7.2B+37.0%$6.9B+36.5%

SHW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SHW quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$1.3B+21.1%$139.1M+327.7%$1.1B+16.9%$1.3B+21.7%$1.1B-7.5%-$61.1M-3.7%$934.5M+1.7%$1.1B-17.9%
Depreciation & Amortization$186.4M+14.6%$186.8M+16.1%$186.4M+15.1%$166.9M+7.3%$162.7M+6.1%$160.9M+5.0%$161.9M+4.9%$155.6M+0.1%
Stock-Based CompensationN/A$29.5M+10.9%N/AN/AN/A$26.6M+8.1%N/AN/A
Capital Expenditures$108.4M-40.3%$138.3M-26.9%$230.4M-23.2%$196.4M-16.5%$181.5M-27.7%$189.3M-33.3%$300.0M-6.1%$235.3M+53.9%
Free Cash Flow$1.2B+33.1%$800K+100.3%$862.1M+35.9%$1.1B+32.4%$931.1M-2.2%-$250.4M+26.9%$634.5M+5.9%$839.4M-27.4%
Investing Cash Flow-$207.7M+13.9%-$170.5M+46.1%-$171.6M+39.9%-$1.3B-306.9%-$241.1M+7.6%-$316.2M+1.6%-$285.5M+46.2%-$328.7M-260.8%
Financing Cash Flow-$1.1B-31.4%$47.6M-87.0%-$942.3M-40.5%$6.5M+100.9%-$810.0M+11.7%$367.2M+26.8%-$670.8M-4.9%-$718.5M+21.5%
Dividends Paid$197.5M-0.2%$197.1M-1.6%$195.8M+8.9%$195.7M+7.2%$197.9M+10.8%$200.4M+9.8%$179.8M+15.8%$182.5M+17.3%
Share Buybacks$1.3B+143.3%$575.6M+63.7%$118.0M-62.0%$668.2M+48.9%$518.5M+19.4%$351.7M-35.5%$310.2M-36.2%$448.7M+9.4%

SHW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SHW quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin49.2%-0.2pp49.1%+0.8pp48.5%-0.1pp49.2%0.0pp49.4%+0.5pp48.2%+1.1pp48.6%+0.1pp49.1%+1.5pp
Operating MarginN/AN/AN/AN/AN/AN/AN/A21.4%+0.2pp
Net Margin12.4%+0.5pp9.4%-0.1pp8.5%-0.5pp13.1%0.0pp11.9%-2.2pp9.5%+0.1pp9.1%+2.3pp13.1%+0.6pp
Return on Equity21.9%+4.7pp12.1%-0.1pp10.4%-1.5pp18.8%-0.6pp17.2%-6.6pp12.2%-2.2pp11.8%+2.3pp19.4%-0.8pp
Return on Assets3.1%+0.2pp2.0%0.0pp1.8%-0.2pp3.2%-0.2pp3.0%-0.8pp2.1%-0.1pp2.0%+0.5pp3.4%+0.1pp
Current Ratio0.73-0.1x0.86+0.1x0.87+0.1x0.820.0x0.780.0x0.770.0x0.790.0x0.83-0.1x
Debt-to-Equity2.16+0.4x2.10+0.2x2.030.0x2.11+0.1x1.78-0.4x1.90-0.4x2.02-0.2x1.97-0.3x
Asset Turnover0.250.0x0.210.0x0.220.0x0.240.0x0.250.0x0.220.0x0.220.0x0.260.0x
FCF Margin18.3%+3.5pp0.0%+4.7pp15.4%+3.4pp17.5%+3.9pp14.8%-0.4pp-4.7%+1.7pp12.0%+0.6pp13.6%-5.3pp

Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
The Sherwin-Williams Company SHW FY2025 $23.6B $2.6B 10.9% $78.8B 54/100
Ecolab, Inc. ECL FY2025 $16.1B $2.1B 12.9% $77.4B 55/100
Air Products & Chemicals, Inc. APD FY2025 $12.0B -$394.5M -3.3% $64.9B 34/100
DuPont de Nemours, Inc. DD FY2025 $6.8B $88.0M 1.3% $17.1B 38/100
PPG Industries, Inc. PPG FY2025 $15.9B $1.6B 9.9% $23.5B 58/100
RPM International, Inc. RPM FY2026 $7.9B $662.0M 8.4% $12.8B 35/100

Frequently Asked Questions

What is The Sherwin-Williams Company's annual revenue?

The Sherwin-Williams Company (SHW) reported $23.6B in total revenue for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Sherwin-Williams Company's revenue growing?

The Sherwin-Williams Company (SHW) revenue grew by 2.1% year-over-year, from $23.1B to $23.6B in fiscal year 2025.

Is The Sherwin-Williams Company profitable?

Yes, The Sherwin-Williams Company (SHW) reported a net income of $2.6B in fiscal year 2025, with a net profit margin of 10.9%.

The Sherwin-Williams Company (SHW) reported diluted earnings per share of $10.26 for fiscal year 2025. This represents a -2.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, The Sherwin-Williams Company (SHW) had $207.2M in cash and equivalents against $9.3B in long-term debt.

The Sherwin-Williams Company (SHW) had a gross margin of 48.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

The Sherwin-Williams Company (SHW) had a net profit margin of 10.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, The Sherwin-Williams Company (SHW) paid $3.16 per share in dividends during fiscal year 2025.

The Sherwin-Williams Company (SHW) has a return on equity of 55.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

The Sherwin-Williams Company (SHW) generated $2.7B in free cash flow during fiscal year 2025. This represents a 27.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

The Sherwin-Williams Company (SHW) generated $3.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

The Sherwin-Williams Company (SHW) had $25.9B in total assets as of fiscal year 2025, including both current and long-term assets.

The Sherwin-Williams Company (SHW) invested $797.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, The Sherwin-Williams Company (SHW) spent $1.7B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

The Sherwin-Williams Company (SHW) had 248M shares outstanding as of fiscal year 2025.

The Sherwin-Williams Company (SHW) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

The Sherwin-Williams Company (SHW) had a debt-to-equity ratio of 2.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

The Sherwin-Williams Company (SHW) had a return on assets of 9.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

The Sherwin-Williams Company (SHW) trades at 29.3x earnings, its market capitalization divided by net income of $2.7B net income, trailing 12 months to June 30, 2026. The market capitalization is $78.8B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

The Sherwin-Williams Company (SHW) trades at 3.2x sales, its market capitalization divided by revenue of $24.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $78.8B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

The Sherwin-Williams Company (SHW) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

The Sherwin-Williams Company (SHW) has an earnings quality ratio of 1.34x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

The Sherwin-Williams Company (SHW) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top